ScholarIQanswers from OpenAlex & ORCID
John M. Kirkwood
ResearcherPublications, citations & collaboration network
John M. Kirkwood is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John M. Kirkwood have?
ScholarIQindexed works
John M. Kirkwood has 1,380 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John M. Kirkwood have?
ScholarIQcitation count
John M. Kirkwood has 93,361 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John M. Kirkwood?
ScholarIQh-index
John M. Kirkwood has an h-index of 138 in OpenAlex.
What is the i10-index of John M. Kirkwood?
ScholarIQi10-index
John M. Kirkwood has an i10-index of 583 in OpenAlex.
What is the ORCID of John M. Kirkwood?
ScholarIQorcid
The ORCID for John M. Kirkwood is on the source record.
What is the OpenAlex record for John M. Kirkwood?
ScholarIQopenalex
The OpenAlex for John M. Kirkwood is on the source record.
What are the most-cited papers on John M. Kirkwood?
ScholarIQmost cited works
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Michael B. Atkins, David R. Byrd, Antônio C. Buzaid, Alistair J. Cochran, Daniel G. Coit, Shouluan Ding, Alexander M.M. Eggermont, Keith T. Flaherty, Phyllis A. Gimotty, John M. Kirkwood, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Arthur J. Sober, Vernon K. Sondak
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Charles M. Balch, Antônio C. Buzaid, Seng‐Jaw Soong, Michael B. Atkins, Natale Cascinelli, Daniel G. Coit, Irvin D. Fleming, Jeffrey E. Gershenwald, Alan N. Houghton, John M. Kirkwood, Kelly M. McMasters, Martin Mihm, Donald L. Morton, Douglas S. Reintgen, Merrick I. Ross, Arthur J. Sober, John A. Thompson, John F. Thompson
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall M. Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David R. Byrd, Renée A. Desmond, Yuting Zhang, Ping‐Yu Liu, Gary H. Lyman, Aberto Morabito
High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190
John M. Kirkwood, Joseph G. Ibrahim, Vernon K. Sondak, Jon Richards, Lawrence E. Flaherty, Marc S. Ernstoff, Thomas J. Smith, Uma Rao, Mary Steele, Ronald H. Blum
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, Jean‐François Baurain, Marcus O. Butler, Max Schlaak, Ryan J. Sullivan, Sebastian Ochsenreither, Reinhard Dummer, John M. Kirkwood, Anthony M. Joshua, Joseph J. Sacco, Alexander N. Shoushtari, Marlana Orloff, Josep M. Piulats, Mohammed Milhem, April K.S. Salama, Brendan D. Curti, Lev Demidov, Lauris Gastaud, Cornelia Mauch, Melinda Yushak, Richard D. Carvajal, Omid Hamid, Shaad E. Abdullah, Chris Holland, Howard Goodall, Sophie Piperno‐Neumann